Cross-Sectional Study of Microalbuminuria and Subclinical TargetOrgan Damage in Essential Hypertension
Background: Microalbuminuria (MAU) is a well-established marker of endothelial dysfunction and early renal injury in essential hypertension. It reflects generalized vascular damage and may predict subclinical cardiac, vascular, and retinal involvement even before overt clinical complications arise. Objectives: To evalu...